{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:02:39Z","timestamp":1791226959690,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s10585-007-9118-2","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T10:24:31Z","timestamp":1195122271000},"page":"609-617","source":"Crossref","is-referenced-by-count":96,"title":["TGF-\u03b2 and BMP7 interactions in tumour progression and bone metastasis"],"prefix":"10.1007","volume":"24","author":[{"given":"Jeroen T.","family":"Buijs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek V.","family":"Henriquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra G. M.","family":"van Overveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertje","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabri","family":"van der Pluijm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,16]]},"reference":[{"key":"9118_CR1","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/carcin\/bgl068","volume":"27","author":"J Seoane","year":"2006","unstructured":"Seoane J (2006) Escaping from the TGFbeta anti-proliferative control. Carcinogenesis 27:2148\u20132156","journal-title":"Carcinogenesis"},{"key":"9118_CR2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442\u2013454","journal-title":"Nat Rev Cancer"},{"key":"9118_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/bcr578","volume":"5","author":"A Vincent-Salomon","year":"2003","unstructured":"Vincent-Salomon A, Thiery JP (2003) Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development. Breast Cancer Res 5:101\u2013106","journal-title":"Breast Cancer Res"},{"key":"9118_CR4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","volume":"15","author":"JP Thiery","year":"2003","unstructured":"Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740\u2013746","journal-title":"Curr Opin Cell Biol"},{"key":"9118_CR5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.150.3698.893","volume":"150","author":"MR Urist","year":"1965","unstructured":"Urist MR (1965) Bone: formation by autoinduction. Science 150:893\u2013899","journal-title":"Science"},{"key":"9118_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/08977190412331279890","volume":"22","author":"D Chen","year":"2004","unstructured":"Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233\u2013241","journal-title":"Growth Factors"},{"key":"9118_CR7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nbt0398-247","volume":"16","author":"AH Reddi","year":"1998","unstructured":"Reddi AH (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16:247\u2013252","journal-title":"Nat Biotechnol"},{"key":"9118_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(00)80196-8","volume":"89","author":"JM Graff","year":"1997","unstructured":"Graff JM (1997) Embryonic patterning: to BMP or not to BMP, that is the question. Cell 89:171\u2013174","journal-title":"Cell"},{"key":"9118_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00003086-199801000-00006","volume":"346","author":"JM Wozney","year":"1998","unstructured":"Wozney JM, Rosen V (1998) Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 346 26\u201337","journal-title":"Clin Orthop Relat Res"},{"key":"9118_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/me.2003-0227","volume":"18","author":"O Avsian-Kretchmer","year":"2004","unstructured":"Avsian-Kretchmer O, Hsueh AJ (2004) Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. Mol Endocrinol 18:1\u201312","journal-title":"Mol Endocrinol"},{"key":"9118_CR11","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1126\/science.280.5368.1455","volume":"280","author":"LJ Brunet","year":"1998","unstructured":"Brunet LJ, McMahon JA, McMahon AP et\u00a0al (1998) Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280:1455\u20131457","journal-title":"Science"},{"key":"9118_CR12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2353\/ajpath.2007.051276","volume":"170","author":"R Schwaninger","year":"2007","unstructured":"Schwaninger R, Rentsch CA, Wetterwald A et\u00a0al (2007) Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases. Am J Pathol 170:160\u2013175","journal-title":"Am J Pathol"},{"key":"9118_CR13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4615-2592-9_12","volume":"71","author":"P Savagner","year":"1994","unstructured":"Savagner P, Boyer B, Valles AM et\u00a0al (1994) Modulations of the epithelial phenotype during embryogenesis and cancer progression. Cancer Treat Res 71:229\u2013249","journal-title":"Cancer Treat Res"},{"key":"9118_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000147748","volume":"154","author":"ED Hay","year":"1995","unstructured":"Hay ED (1995) An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 154:8\u201320","journal-title":"Acta Anat (Basel)"},{"key":"9118_CR15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01833264","volume":"24","author":"SN Bae","year":"1993","unstructured":"Bae SN, Arand G, Azzam H et\u00a0al (1993) Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in\u00a0vitro assays. Breast Cancer Res Treat 24:241\u2013255","journal-title":"Breast Cancer Res Treat"},{"key":"9118_CR16","unstructured":"Weinberg RA (2007) The biology of cancer, 1st edn. Garland Science, Taylor & Francis Group"},{"key":"9118_CR17","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1128\/MCB.22.5.1474-1487.2002","volume":"22","author":"U Dahl","year":"2002","unstructured":"Dahl U, Sjodin A, Larue L et\u00a0al (2002) Genetic dissection of cadherin function during nephrogenesis. Mol Cell Biol 22:1474\u20131487","journal-title":"Mol Cell Biol"},{"key":"9118_CR18","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1073\/pnas.93.17.9021","volume":"93","author":"S Vukicevic","year":"1996","unstructured":"Vukicevic S, Kopp JB, Luyten FP et\u00a0al (1996) Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7). Proc Natl Acad Sci USA 93:9021\u20139026","journal-title":"Proc Natl Acad Sci USA"},{"key":"9118_CR19","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1101\/gad.9.22.2808","volume":"9","author":"G Luo","year":"1995","unstructured":"Luo G, Hofmann C, Bronckers AL et\u00a0al (1995) BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 9:2808\u20132820","journal-title":"Genes Dev"},{"key":"9118_CR20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776\u20131784","journal-title":"J Clin Invest"},{"key":"9118_CR21","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1093\/emboj\/20.9.2254","volume":"20","author":"T Alliston","year":"2001","unstructured":"Alliston T, Choy L, Ducy P et\u00a0al (2001) TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20:2254\u20132272","journal-title":"EMBO J"},{"key":"9118_CR22","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1242\/dev.128.21.4241","volume":"128","author":"R Haraguchi","year":"2001","unstructured":"Haraguchi R, Mo R, Hui C et\u00a0al (2001) Unique functions of Sonic hedgehog signaling during external genitalia development. Development 128:4241\u20134250","journal-title":"Development"},{"key":"9118_CR23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/excr.2002.5630","volume":"280","author":"T Muller","year":"2002","unstructured":"Muller T, Bain G, Wang X et\u00a0al (2002) Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Exp Cell Res 280:119","journal-title":"Exp Cell Res"},{"key":"9118_CR24","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/PL00000650","volume":"57","author":"CM Chuong","year":"2000","unstructured":"Chuong CM, Patel N, Lin J et\u00a0al (2000) Sonic hedgehog signaling pathway in vertebrate epithelial appendage morphogenesis: perspectives in development and evolution. Cell Mol Life Sci 57:1672\u20131681","journal-title":"Cell Mol Life Sci"},{"key":"9118_CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/35077219","volume":"411","author":"J Taipale","year":"2001","unstructured":"Taipale J, Beachy PA (2001) The Hedgehog and Wnt signalling pathways in cancer. Nature 411:349\u2013354","journal-title":"Nature"},{"key":"9118_CR26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00041552-200105000-00021","volume":"10","author":"J Barasch","year":"2001","unstructured":"Barasch J (2001) Genes and proteins involved in mesenchymal to epithelial transition. Curr Opin Nephrol Hypertens 10:429\u2013436","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"9118_CR27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0006-2952(00)00427-5","volume":"60","author":"B Boyer","year":"2000","unstructured":"Boyer B, Valles AM, Edme N (2000) Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60:1091\u20131099","journal-title":"Biochem Pharmacol"},{"key":"9118_CR28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/bies.1132","volume":"23","author":"P Savagner","year":"2001","unstructured":"Savagner P (2001) Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23:912\u2013923","journal-title":"Bioessays"},{"key":"9118_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cell.2004.07.011","volume":"118","author":"Y Kang","year":"2004","unstructured":"Kang Y, Massague J (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118:277\u2013279","journal-title":"Cell"},{"key":"9118_CR30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1090922","volume":"303","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Chytil A, Plieth D et\u00a0al (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848\u2013851","journal-title":"Science"},{"key":"9118_CR31","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1172\/JCI200318899","volume":"112","author":"B Tang","year":"2003","unstructured":"Tang B, Vu M, Booker T et\u00a0al (2003) TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 112:1116\u20131124","journal-title":"J Clin Invest"},{"key":"9118_CR32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"1","author":"S Paget","year":"1889","unstructured":"Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571\u2013573","journal-title":"Lancet"},{"key":"9118_CR33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","volume":"411","author":"LA Liotta","year":"2001","unstructured":"Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375\u2013379","journal-title":"Nature"},{"key":"9118_CR34","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1432-0436.2002.700904.x","volume":"70","author":"IJ Fidler","year":"2002","unstructured":"Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70:498\u2013505","journal-title":"Differentiation"},{"key":"9118_CR35","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.euus.2005.09.006","volume":"3","author":"MG Cecchini","year":"2005","unstructured":"Cecchini MG, Wetterwald A, van der Pluijm G et\u00a0al (2005) Molecular and biological mechanisms of bone metastasis. EAU Update Series 3:214","journal-title":"EAU Update Series"},{"key":"9118_CR36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/bjc.1987.225","volume":"56","author":"RE Coleman","year":"1987","unstructured":"Coleman RE, Rubens RD (1987) 3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer. Br J Cancer 56:465\u2013469","journal-title":"Br J Cancer"},{"key":"9118_CR37","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2002.11.080","volume":"20","author":"T Powles","year":"2002","unstructured":"Powles T, Paterson S, Kanis JA et\u00a0al (2002) Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol 20:3219\u20133224","journal-title":"J Clin Oncol"},{"key":"9118_CR38","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0277-5379(86)90117-3","volume":"22","author":"JW Elte","year":"1986","unstructured":"Elte JW, Bijvoet OL, Cleton FJ et\u00a0al (1986) Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment. Eur J Cancer Clin Oncol 22:493\u2013500","journal-title":"Eur J Cancer Clin Oncol"},{"key":"9118_CR39","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(87)92555-4","volume":"2","author":"AT Holten-Verzantvoort van","year":"1987","unstructured":"van Holten-Verzantvoort AT, Bijvoet OL, Cleton FJ et\u00a0al (1987) Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet 2:983\u2013985","journal-title":"Lancet"},{"key":"9118_CR40","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","volume":"80","author":"RE Coleman","year":"1997","unstructured":"Coleman RE (1997) Skeletal complications of malignancy. Cancer 80:1588\u20131594","journal-title":"Cancer"},{"key":"9118_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0305-7372(03)00071-9","volume":"29","author":"CL Eaton","year":"2003","unstructured":"Eaton CL, Coleman RE (2003) Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment. Cancer Treat Rev 29:189\u2013198","journal-title":"Cancer Treat Rev"},{"key":"9118_CR42","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-06-2490","volume":"67","author":"JT Buijs","year":"2007","unstructured":"Buijs JT, Henriquez NV, van der Horst G et\u00a0al (2007) Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Cancer Res 67:8742\u20138751","journal-title":"Cancer Res"},{"issue":"3","key":"9118_CR43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2353\/ajpath.2007.070168","volume":"171","author":"JT Buijs","year":"2007","unstructured":"Buijs JT, Rentsch CA, van der Horst G et\u00a0al (2007) BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in\u00a0vivo. Am J Pathol 171(3):1047\u20131057","journal-title":"Am J Pathol"},{"key":"9118_CR44","doi-asserted-by":"crossref","first-page":"7682","DOI":"10.1158\/0008-5472.CAN-04-4188","volume":"65","author":"G Pluijm van der","year":"2005","unstructured":"van der Pluijm G, Que I, Sijmons B et\u00a0al (2005) Interference with the microenvironmental support impairs the de novo formation of bone metastases in\u00a0vivo. Cancer Res 65:7682\u20137690","journal-title":"Cancer Res"},{"key":"9118_CR45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/206489a0","volume":"206","author":"R Hattner","year":"1965","unstructured":"Hattner R, Epker BN, Frost HM (1965) Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 206:489\u2013490","journal-title":"Nature"},{"key":"9118_CR46","first-page":"3","volume-title":"Bone histomorphometry","author":"EF Eriksen","year":"1994","unstructured":"Eriksen EF, Axelrod DW, Melsen F (1994) Bone histomorphometry. Raven Press, New York, pp 3\u201312"},{"key":"9118_CR47","unstructured":"Mundy GR, Chen D, Oyajobi BO (2003) Bone remodelling. In: Favus M (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, Washington, pp 46\u201358"},{"key":"9118_CR48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584\u2013593","journal-title":"Nat Rev Cancer"},{"key":"9118_CR49","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350:1655\u201364","journal-title":"N Engl J Med"},{"key":"9118_CR50","first-page":"1","volume-title":"Bone metastasis\u2014mechanisms and pathophysiology","author":"GR Mundy","year":"1996","unstructured":"Mundy GR, Yoneda T (1996) Mechanisms of bone metastasis. In: Singh G (ed) Bone metastasis\u2014mechanisms and pathophysiology. Springer, Heidelberg, pp 1\u201316"},{"key":"9118_CR51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","volume":"103","author":"JJ Yin","year":"1999","unstructured":"Yin JJ, Selander K, Chirgwin JM et\u00a0al (1999) TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 103:197\u2013206","journal-title":"J Clin Invest"},{"key":"9118_CR52","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise TA, Yin JJ, Taylor SD et\u00a0al (1996) Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Invest 98:1544\u20131549","journal-title":"J Clin Invest"},{"key":"9118_CR53","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","volume":"140","author":"RJ Thomas","year":"1999","unstructured":"Thomas RJ, Guise TA, Yin JJ (1999) Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140:4451\u20134458","journal-title":"Endocrinology"},{"key":"9118_CR54","doi-asserted-by":"crossref","unstructured":"Guise TA, Chirgwin JM (2003) Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop Relat Res 415(Suppl):S32\u2013S38","DOI":"10.1097\/01.blo.0000093055.96273.69"},{"key":"9118_CR55","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1158\/0008-5472.CAN-05-3560","volume":"66","author":"M Deckers","year":"2006","unstructured":"Deckers M, van Dinther M, Buijs J et\u00a0al (2006) The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res 66:2202\u20132209","journal-title":"Cancer Res"},{"key":"9118_CR56","doi-asserted-by":"crossref","first-page":"13909","DOI":"10.1073\/pnas.0506517102","volume":"102","author":"Y Kang","year":"2005","unstructured":"Kang Y, He W, Tulley S et\u00a0al (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc Natl Acad Sci USA 102:13909\u201313914","journal-title":"Proc Natl Acad Sci USA"},{"key":"9118_CR57","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/0008-5472.CAN-06-3950","volume":"67","author":"D Javelaud","year":"2007","unstructured":"Javelaud D, Mohammad KS, McKenna CR et\u00a0al (2007) Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res 67:2317\u20132324","journal-title":"Cancer Res"},{"key":"9118_CR58","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1464-410x.1999.00378.x","volume":"84","author":"AA Bryden","year":"1999","unstructured":"Bryden AA, Freemont AJ, Clarke NW et\u00a0al (1999) Paradoxical expression of E-cadherin in prostatic bone metastases. BJU Int 84:1032\u20131034","journal-title":"BJU Int"},{"key":"9118_CR59","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1464-4096.2001.01712.x","volume":"89","author":"AA Bryden","year":"2002","unstructured":"Bryden AA, Hoyland JA, Freemont A et\u00a0al (2002) E-cadherin and beta-catenin are down-regulated in prostatic bone metastases. BJU Int 89:400\u2013403","journal-title":"BJU Int"},{"key":"9118_CR60","doi-asserted-by":"crossref","first-page":"8319","DOI":"10.1158\/0008-5472.CAN-06-0410","volume":"66","author":"JJ Christiansen","year":"2006","unstructured":"Christiansen JJ, Rajasekaran AK (2006) Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 66:8319\u20138326","journal-title":"Cancer Res"},{"key":"9118_CR61","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0002-9440(10)64934-6","volume":"160","author":"A Wetterwald","year":"2002","unstructured":"Wetterwald A, van der Pluijm G, Que I et\u00a0al (2002) Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160:1143\u20131153","journal-title":"Am J Pathol"},{"key":"9118_CR62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo SG, Reynolds BA, Zanetti N et\u00a0al (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444:761\u2013765","journal-title":"Nature"},{"key":"9118_CR63","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A et\u00a0al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100:3983\u20133988","journal-title":"Proc Natl Acad Sci USA"},{"key":"9118_CR64","doi-asserted-by":"crossref","first-page":"7274","DOI":"10.1038\/sj.onc.1207947","volume":"23","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Clarke MF (2004) Self-renewal and solid tumor stem cells. Oncogene 23:7274\u20137282","journal-title":"Oncogene"},{"key":"9118_CR65","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","volume":"65","author":"AT Collins","year":"2005","unstructured":"Collins AT, Berry PA, Hyde C et\u00a0al (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65:10946\u201310951","journal-title":"Cancer Res"},{"key":"9118_CR66","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/j.1464-410X.2005.05744.x","volume":"96","author":"NJ Maitland","year":"2005","unstructured":"Maitland NJ, Collins A (2005) A tumour stem cell hypothesis for the origins of prostate cancer. BJU Int 96:1219\u20131223","journal-title":"BJU Int"},{"key":"9118_CR67","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.ejca.2006.01.037","volume":"42","author":"AT Collins","year":"2006","unstructured":"Collins AT, Maitland NJ (2006) Prostate cancer stem cells. Eur J Cancer 42:1213\u20131218","journal-title":"Eur J Cancer"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9118-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-007-9118-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9118-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T20:15:55Z","timestamp":1630095355000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-007-9118-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["9118"],"URL":"https:\/\/doi.org\/10.1007\/s10585-007-9118-2","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}